Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Peuskens

Showing results (31-40 of 75) with videos related to

Pageof 8
Sort By:
The Journal of ECT|March 26, 2005
Electroconvulsive therapy in Belgium: a questionnaire study on the practice of electroconvulsive therapy in Flanders and the Brussels Capital regionPascal Sienaert, Filip Bouckaert, Bouckaert Filip, et al.
Current Medical Research and Opinion|November 22, 2002
A double-blind, randomised comparative trial of amisulpride versus olanzapine in the treatment of schizophrenia: short-term results at two monthsStephen Martin, Henri Lĵo, Joseph Peuskens, et al.
The Journal of ECT|April 2, 2008
Overgeneral memory predicts stability of short-term outcome of electroconvulsive therapy for depressionFilip Raes, Pascal Sienaert, Koen Demyttenaere, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 20, 2013
Subjective well-being in schizophrenia: a randomised controlled open-label 12-month non-inferiority study comparing quetiapine XR with risperidone (RECOVER)Dieter Naber, Joseph Peuskens, Nadine Schwarzmann, et al.
Schizophrenia Research|March 6, 2007
Remission criteria for schizophrenia: evaluation in a large naturalistic cohortMarc De Hert, Ruud van Winkel, Martien Wampers, et al.
Clinical Schizophrenia & Related Psychoses|June 23, 2011
Knowledge about HIV in people with schizophrenia: a general population comparisonMarc De Hert, Leen Trappeniers, Martien Wampers, et al.
Schizophrenia Research|September 4, 2007
Remission in schizophrenia: applying recent consensus criteria to refine the conceptRobert A Lasser, Henry Nasrallah, Lars Helldin, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 3, 2014
Extrapyramidal symptoms during treatment of first schizophrenia episode: results from EUFESTJanusz K Rybakowski, Kristof Vansteelandt, Agnieszka Remlinger-Molenda, et al.
Psychiatry (Edgmont (Pa. : Township))|April 30, 2010
Prevention of schizophrenia relapse with extended release quetiapine fumarate dosed once daily: a randomized, placebo-controlled trial in clinically stable patientsJoseph Peuskens, Jitendra Trivedi, Sergiy Malyarov, et al.
Schizophrenia Research|June 16, 2010
MTHFR and risk of metabolic syndrome in patients with schizophreniaRuud van Winkel, Bart P Rutten, Odette Peerbooms, et al.
Pageof 8

Showing results (31-40 of 75) with videos related to

Sort By:
Pageof 8
The Journal of ECT|March 26, 2005
Electroconvulsive therapy in Belgium: a questionnaire study on the practice of electroconvulsive therapy in Flanders and the Brussels Capital regionPascal Sienaert, Filip Bouckaert, Bouckaert Filip, et al.
Current Medical Research and Opinion|November 22, 2002
A double-blind, randomised comparative trial of amisulpride versus olanzapine in the treatment of schizophrenia: short-term results at two monthsStephen Martin, Henri Lĵo, Joseph Peuskens, et al.
The Journal of ECT|April 2, 2008
Overgeneral memory predicts stability of short-term outcome of electroconvulsive therapy for depressionFilip Raes, Pascal Sienaert, Koen Demyttenaere, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 20, 2013
Subjective well-being in schizophrenia: a randomised controlled open-label 12-month non-inferiority study comparing quetiapine XR with risperidone (RECOVER)Dieter Naber, Joseph Peuskens, Nadine Schwarzmann, et al.
Schizophrenia Research|March 6, 2007
Remission criteria for schizophrenia: evaluation in a large naturalistic cohortMarc De Hert, Ruud van Winkel, Martien Wampers, et al.
Clinical Schizophrenia & Related Psychoses|June 23, 2011
Knowledge about HIV in people with schizophrenia: a general population comparisonMarc De Hert, Leen Trappeniers, Martien Wampers, et al.
Schizophrenia Research|September 4, 2007
Remission in schizophrenia: applying recent consensus criteria to refine the conceptRobert A Lasser, Henry Nasrallah, Lars Helldin, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 3, 2014
Extrapyramidal symptoms during treatment of first schizophrenia episode: results from EUFESTJanusz K Rybakowski, Kristof Vansteelandt, Agnieszka Remlinger-Molenda, et al.
Psychiatry (Edgmont (Pa. : Township))|April 30, 2010
Prevention of schizophrenia relapse with extended release quetiapine fumarate dosed once daily: a randomized, placebo-controlled trial in clinically stable patientsJoseph Peuskens, Jitendra Trivedi, Sergiy Malyarov, et al.
Schizophrenia Research|June 16, 2010
MTHFR and risk of metabolic syndrome in patients with schizophreniaRuud van Winkel, Bart P Rutten, Odette Peerbooms, et al.
Pageof 8